139 related articles for article (PubMed ID: 31269283)
1. Fibroblast as a critical stromal cell type determining prognosis in prostate cancer.
Blom S; Erickson A; Östman A; Rannikko A; Mirtti T; Kallioniemi O; Pellinen T
Prostate; 2019 Sep; 79(13):1505-1513. PubMed ID: 31269283
[TBL] [Abstract][Full Text] [Related]
2. Intensity of stromal changes is associated with tumor relapse in clinically advanced prostate cancer after castration therapy.
Wu JP; Huang WB; Zhou H; Xu LW; Zhao JH; Zhu JG; Su JH; Sun HB
Asian J Androl; 2014; 16(5):710-4. PubMed ID: 24875819
[TBL] [Abstract][Full Text] [Related]
3. Characterizing the molecular features of ERG-positive tumors in primary and castration resistant prostate cancer.
Roudier MP; Winters BR; Coleman I; Lam HM; Zhang X; Coleman R; Chéry L; True LD; Higano CS; Montgomery B; Lange PH; Snyder LA; Srivastava S; Corey E; Vessella RL; Nelson PS; Üren A; Morrissey C
Prostate; 2016 Jun; 76(9):810-22. PubMed ID: 26990456
[TBL] [Abstract][Full Text] [Related]
4. Modulating tumor reactive stroma by extracorporeal shock waves to control prostate cancer progression.
Rinella L; Pizzo B; Frairia R; Delsedime L; Calleris G; Gontero P; Zunino V; Fortunati N; Arvat E; Catalano MG
Prostate; 2020 Sep; 80(13):1087-1096. PubMed ID: 32609927
[TBL] [Abstract][Full Text] [Related]
5. Stromal factors involved in human prostate cancer development, progression and castration resistance.
Eiro N; Fernandez-Gomez J; Sacristán R; Fernandez-Garcia B; Lobo B; Gonzalez-Suarez J; Quintas A; Escaf S; Vizoso FJ
J Cancer Res Clin Oncol; 2017 Feb; 143(2):351-359. PubMed ID: 27787597
[TBL] [Abstract][Full Text] [Related]
6. Ratiometric Inclusion of Fibroblasts Promotes Both Castration-Resistant and Androgen-Dependent Tumorigenic Progression in Engineered Prostate Cancer Tissues.
Habbit NL; Anbiah B; Suresh J; Anderson L; Davies ML; Hassani I; Ghosh TM; Greene MW; Prabhakarpandian B; Arnold RD; Lipke EA
Adv Healthc Mater; 2023 Dec; 12(32):e2301139. PubMed ID: 37450342
[TBL] [Abstract][Full Text] [Related]
7. RGS2 is prognostic for development of castration resistance and cancer-specific survival in castration-resistant prostate cancer.
Linder A; Larsson K; Welén K; Damber JE
Prostate; 2020 Aug; 80(11):799-810. PubMed ID: 32449815
[TBL] [Abstract][Full Text] [Related]
8. The prognostic significance of OCT4 expression in patients with prostate cancer.
Kosaka T; Mikami S; Yoshimine S; Miyazaki Y; Daimon T; Kikuchi E; Miyajima A; Oya M
Hum Pathol; 2016 May; 51():1-8. PubMed ID: 27067776
[TBL] [Abstract][Full Text] [Related]
9. Expression of store-operated channel components in prostate cancer: the prognostic paradox.
Perrouin Verbe MA; Bruyere F; Rozet F; Vandier C; Fromont G
Hum Pathol; 2016 Mar; 49():77-82. PubMed ID: 26826413
[TBL] [Abstract][Full Text] [Related]
10. Kallikrein-related peptidase 4 induces cancer-associated fibroblast features in prostate-derived stromal cells.
Kryza T; Silva LM; Bock N; Fuhrman-Luck RA; Stephens CR; Gao J; Samaratunga H; ; Lawrence MG; Hooper JD; Dong Y; Risbridger GP; Clements JA
Mol Oncol; 2017 Oct; 11(10):1307-1329. PubMed ID: 28510269
[TBL] [Abstract][Full Text] [Related]
11. Asporin is a stromally expressed marker associated with prostate cancer progression.
Rochette A; Boufaied N; Scarlata E; Hamel L; Brimo F; Whitaker HC; Ramos-Montoya A; Neal DE; Dragomir A; Aprikian A; Chevalier S; Thomson AA
Br J Cancer; 2017 Mar; 116(6):775-784. PubMed ID: 28152543
[TBL] [Abstract][Full Text] [Related]
12. The Role of PCA 3 as a Prognostic Factor in Patients with Castration-resistant Prostate Cancer (CRPC) Treated with Docetaxel.
Bourdoumis A; Chrisofos M; Stasinou T; Christopoulos P; Mourmouris P; Kostakopoulos A; Deliveliotis C
Anticancer Res; 2015 May; 35(5):3075-9. PubMed ID: 25964598
[TBL] [Abstract][Full Text] [Related]
13. Elevated S100A8 protein expression in breast cancer cells and breast tumor stroma is prognostic of poor disease outcome.
Miller P; Kidwell KM; Thomas D; Sabel M; Rae JM; Hayes DF; Hudson BI; El-Ashry D; Lippman ME
Breast Cancer Res Treat; 2017 Nov; 166(1):85-94. PubMed ID: 28717852
[TBL] [Abstract][Full Text] [Related]
14. Fibroblast heterogeneity in prostate carcinogenesis.
ChallaSivaKanaka S; Vickman RE; Kakarla M; Hayward SW; Franco OE
Cancer Lett; 2022 Jan; 525():76-83. PubMed ID: 34715252
[TBL] [Abstract][Full Text] [Related]
15. Identification of PRL1 as a novel diagnostic and therapeutic target for castration-resistant prostate cancer by the Escherichia coli ampicillin secretion trap (CAST) method.
Shinmei S; Sentani K; Hayashi T; Sakamoto N; Goto K; Oo HZ; Naito Y; Teishima J; Matsubara A; Oue N; Kuniyasu H; Yasui W
Urol Oncol; 2014 Aug; 32(6):769-78. PubMed ID: 24968948
[TBL] [Abstract][Full Text] [Related]
16. Phenotypic characterization of human prostatic stromal cells in primary cultures derived from human tissue samples.
Gravina GL; Mancini A; Ranieri G; Di Pasquale B; Marampon F; Di Clemente L; Ricevuto E; Festuccia C
Int J Oncol; 2013 Jun; 42(6):2116-22. PubMed ID: 23589051
[TBL] [Abstract][Full Text] [Related]
17. Novel nomograms for castration-resistant prostate cancer and survival outcome in patients with de novo bone metastatic prostate cancer.
Zhao J; Sun G; Liao B; Zhang X; Armstrong CM; Yin X; Liu J; Chen J; Yang Y; Zhao P; Tang Q; Wang Z; Chen Z; Li X; Wei Q; Li X; Chen N; Gao AC; Shen P; Zeng H
BJU Int; 2018 Dec; 122(6):994-1002. PubMed ID: 29772102
[TBL] [Abstract][Full Text] [Related]
18. Paracrine sonic hedgehog signaling contributes significantly to acquired steroidogenesis in the prostate tumor microenvironment.
Lubik AA; Nouri M; Truong S; Ghaffari M; Adomat HH; Corey E; Cox ME; Li N; Guns ES; Yenki P; Pham S; Buttyan R
Int J Cancer; 2017 Jan; 140(2):358-369. PubMed ID: 27672740
[TBL] [Abstract][Full Text] [Related]
19. Reactive stroma in human prostate cancer: induction of myofibroblast phenotype and extracellular matrix remodeling.
Tuxhorn JA; Ayala GE; Smith MJ; Smith VC; Dang TD; Rowley DR
Clin Cancer Res; 2002 Sep; 8(9):2912-23. PubMed ID: 12231536
[TBL] [Abstract][Full Text] [Related]
20. Clinical and functional significance of tumor/stromal ATR expression in breast cancer patients.
Al-Ansari MM; Al-Saif M; Arafah M; Eldali AM; Tulbah A; Al-Tweigeri T; Semlali A; Khabar KS; Aboussekhra A
Breast Cancer Res; 2020 May; 22(1):49. PubMed ID: 32414408
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
